✦ LIBER ✦

A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome

✍ Scribed by JD Horbar; RF Soll; JM Sutherland; U Kotagal; AGS Philip; DL Kessler; GA Little; WH Edwards; D Vidyasagar; TNK Raju; AH Jobe; M Ikegami; MD Mullet; DZ Myerberg; TL McAuliffe; JF Lucey

Book ID: 118888938
Publisher: Elsevier Science
Year: 1989
Tongue: English
Weight: 124 KB
Volume: 30
Category: Article
ISSN: 0020-7292
DOI: 10.1016/0020-7292(89)90317-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A European multicenter randomized contro

A European multicenter randomized controlled trial of single dose surfactant therapy for idiopathic respiratory distress syndrome

✍ J. D. Horbar; R. F. Soll; H. Schachinger; G. Kewitz; H. T. Versmold; W. Lindner; 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 904 KB

A multicenter randomized controlled clin

A multicenter randomized controlled clinical trial of bovine surfactant for prevention of respiratory distress syndrome

✍ L. Gortner; U. Bernsau; H. H. Hellwege; G. Hieronimi; G. Jorch; H. L. Reiter 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 256 KB

Early surfactant for neonates with mild

Early surfactant for neonates with mild to moderate respiratory distress syndrome: a multicenter, randomized trial

✍ The Texas Neonatal Research Group 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 120 KB

A multicenter randomized trial comparing

A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome

✍ Jeffery D. Horbar; Linda L. Wright; Roger F. Soll; Elizabeth C. Wright; Avroy A. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 839 KB

Surfactant replacement therapy for sever

Surfactant replacement therapy for severe neonatal respiratory distress syndrome: Biometrical aspects and results of the European multicenter randomized clinical trial

✍ Olaf Gefeller; Daniele Compagnone; Christian P. Speer 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 149 KB

A multicenter randomized placebo-control

A multicenter randomized placebo-controlled clinical trial of pramipexole for Tourette's syndrome

✍ Roger Kurlan; Giovanna Crespi; Barbara Coffey; Kirsten Mueller-Vahl; Stephen Kov 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 730 KB

Background: Dopamine agonists could theoretically normalize the suspected central dopamine hypersensitivity in Tourette's syndrome. Methods: There was a multicenter randomized, placebo-controlled, double-blind clinical trial of pramipexole given for 6 weeks in 63 children and adolescents with Touret